Beel, Stephanie; Kolloch, Lina; Apken, Lisa; Jürgens, Lara, Bolle, Andrea; Sudhof, Nadine, Ghosh, Sankar; Wardelmann, Eva; Meisterernst, Michael; Steinestel, Konrad; Oeckinghaus, Andrea
Research article (journal) | Peer reviewedPancreatic ductal adenocarcinoma (PDAC) is associated with high mortality and therapy resistance. Here, we show that low expression of κB-Ras GTPases is frequently detected in PDAC and correlates with higher histologic grade. In a model of KRasG12D-driven PDAC, loss of κB-Ras accelerates tumour development and shortens median survival. κB-Ras deficiency promotes acinar-to-ductal metaplasia (ADM) during tumour initiation as well as tumour progression through intrinsic effects on proliferation and invasion. κB-Ras proteins are also required for acinar regeneration after pancreatitis, demonstrating a general role in control of plasticity. Molecularly, upregulation of Ral GTPase activity and Sox9 expression underlies the observed phenotypes, identifying a previously unrecognized function of Ral signalling in ADM. Our results provide evidence for a tumour suppressive role of κB-Ras proteins and highlight low κB-Ras levels and consequent loss of Ral control as risk factors, thus emphasizing the necessity for therapeutic options that allow interference with Ral-driven signalling.
Apken, Lisa Helene | Institute of Molecualr Tumor Biology |
Beel, Stephanie | Institute of Molecualr Tumor Biology |
Kolloch, Lina Jenny | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
Meisterernst, Michael | Institute of Molecualr Tumor Biology |
Oeckinghaus, Andrea Marion | Institute of Molecualr Tumor Biology |
Wardelmann, Eva Erika | Gerhard Domagk Institute of Pathology |